Neuroscience
Modifying the microbiota could influence multiple sclerosis progression and provide new therapeutic targets.
Gastroenterology
Gut microbes adapt to exercise demands, favoring energy production over bacterial diversity.
Gastroenterology
From gut flora to fermented milk, his discoveries still shape modern microbiome science.
Video
At the upcoming Probiotic, Prebiotic and New Food Congress, Professor Willem de Vos, University of Helsinki, will explore emerging insights into the role of dietary fibers and their transformation into…
Industry, Neuroscience
MaaT Pharma’s venture marks an innovative and hopeful chapter in the ongoing effort to fight neurodegeneration.
Gastroenterology
Targeting TudS could be a potential therapeutic approach for treating C. difficile infections.
Oncology, Gastroenterology
Each Fusobacterium nucleatum population has unique traits and distribution patterns across body sites and conditions such as colorectal cancer and Crohn’s disease.
Healthcare professionals area, Industry
Access the full report on Europe's probiotic market trends on Amazon, with comprehensive data on search volumes, keyword strategies, pricing analysis and market penetration.
Neuroscience, Gastroenterology
Gut microbiota-produced bile acids can be used as therapeutic targets for multiple sclerosis.
Scientific research
Probiotic supplementation improves sports performance by enhancing nutrient absorption, immune function, and endurance while reducing anxiety and gastrointestinal symptoms.